Investor profile
Northpond Ventures has backed 7 European tech companies across 8 funding rounds between 2018 and 2022, joining rounds totalling €356M. Most active in Healthtech and Software. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Ori Biotech | UK | 2 | €114M |
| OMass Therapeutics | UK | 1 | €90M |
| Transition Bio | UK | 1 | €47M |
| Opna Bio | Switzerland | 1 | €37M |
| Current Health | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| OMass Therapeutics | Series B | €90M | 2022-04 |
| Ori Biotech | Series B | €88M | 2022-01 |
| Transition Bio | Series A | €47M | 2022-06 |
| Opna Bio |
| 1 |
| €36M |
| Teckro | Ireland | 1 | €22M |
| Molecule | Germany | 1 | €12M |
| Series A |
| €37M |
| 2022-11 |
| Current Health | Series B | €36M | 2021-04 |
| Ori Biotech | Series A | €26M | 2020-10 |
| Teckro | Series C | €22M | 2019-01 |
| Molecule | Other | €12M | 2022-06 |
